Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Inozyme Pharma Inc. (INZY)

  • SEC News
  • July 02, 2025, 10:02 UTC
  • 1

New Form EFFECT - Inozyme Pharma, Inc. Filed: 2025-07-01 AccNo: 9999999995-25-002110 Size: 1 KB

Comment Full text

Regulus Therapeutics Inc. (RGLS)

  • SEC News
  • July 02, 2025, 10:02 UTC
  • 1

New Form EFFECT - Regulus Therapeutics Inc. Filed: 2025-07-01 AccNo: 9999999995-25-002105 Size: 1 KB

Comment Full text

Regulus Therapeutics Inc. (RGLS)

  • SEC News
  • July 02, 2025, 10:02 UTC
  • 1

New Form EFFECT - Regulus Therapeutics Inc. Filed: 2025-07-01 AccNo: 9999999995-25-002104 Size: 1 KB

Comment Full text

Kineta Inc (KA)

  • SEC News
  • July 02, 2025, 10:02 UTC
  • 1

New Form EFFECT - KINETA, INC./DE Filed: 2025-07-01 AccNo: 9999999995-25-002113 Size: 2 KB

Comment Full text

Regulus Therapeutics Inc. (RGLS)

  • SEC News
  • July 02, 2025, 10:02 UTC
  • 1

New Form EFFECT - Regulus Therapeutics Inc. Filed: 2025-07-01 AccNo: 9999999995-25-002112 Size: 1 KB

Comment Full text

Inozyme Pharma Inc. (INZY)

  • SEC News
  • July 02, 2025, 10:02 UTC
  • 1

New Form EFFECT - Inozyme Pharma, Inc. Filed: 2025-07-01 AccNo: 9999999995-25-002117 Size: 1 KB

Comment Full text

Regulus Therapeutics Inc. (RGLS)

  • SEC News
  • July 02, 2025, 10:02 UTC
  • 1

New Form EFFECT - Regulus Therapeutics Inc. Filed: 2025-07-01 AccNo: 9999999995-25-002119 Size: 1 KB

Comment Full text

Regulus Therapeutics Inc. (RGLS)

  • SEC News
  • July 02, 2025, 10:02 UTC
  • 1

New Form EFFECT - Regulus Therapeutics Inc. Filed: 2025-07-01 AccNo: 9999999995-25-002118 Size: 1 KB

Comment Full text

Kineta Inc (KA)

  • SEC News
  • July 02, 2025, 10:02 UTC
  • 1

New Form EFFECT - KINETA, INC./DE Filed: 2025-07-01 AccNo: 9999999995-25-002116 Size: 2 KB

Comment Full text

IHH Healthcare Berhad (Q0F)

  • SEC News
  • July 02, 2025, 09:29 UTC
  • 1

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Comment Full text
  • Previous
  • 71
  • 72
  • 73
  • 74
  • 75
  • Next

Search

News categories

  • Technical Exchange News(9492)
  • Event(407)
  • SEC News(155850)
  • FDA Approval(8880)
  • Company Report(721)
  • Business News(105742)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin